» Articles » PMID: 27289275

Calcification of Vascular Smooth Muscle Cells is Induced by Secondary Calciprotein Particles and Enhanced by Tumor Necrosis Factor-α

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2016 Jun 13
PMID 27289275
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Vascular calcification is prevalent in clinical states characterized by low-grade chronic inflammation, such as chronic kidney disease (CKD). Calciprotein particles (CPP) are calcium phosphate-containing nano-aggregates, which have been found in the blood of CKD patients and appear pro-inflammatory in vitro. The interplay of CPPs and inflammatory cytokines with regard to the calcification of vascular smooth muscle cells (VSMC), in vitro, has not been investigated yet.

Methods: Primary or secondary CPP were generated using phosphate-enriched culture medium (DMEM/10% FBS) incubated at 37 °C. Human VSMC were cultured with these media and mineralization was measured. Expression of TNF-α was detected by qPCR, ELISA and Western blot in calcified VSMC. To further characterize the significance of TNF-α and its receptors for the calcification of VSMC, RNA interference experiments using siTNF-α, siTNFR1 and siTNFR2 were performed.

Results: The addition of phosphate to cell culture medium containing DMEM/10% FBS led to the rapid formation of primary CPP, which underwent spontaneous transformation to secondary CPP. Exposure of VSMC towards secondary CPP led to pronounced and concentration-dependent calcification, whereas exposure towards primary CPP did not. Importantly, secondary CPP induced oxidative stress, and led to the up-regulation and release of TNF-α. Addition of TNF-α to the cell culture medium enhanced, whereas the suppression of endogenous TNF-α or TNF receptor type 1 (TNFR1) expression by siRNA, ameliorated calcification.

Conclusions: Secondary, but not primary CPP, induce VSMC calcification. Secondary CPP induce the expression and release of TNF-α, which enhances calcification via its receptor TNFR1.

Citing Articles

Size-dependent interactions between calciprotein particles and vascular endothelium.

Zhang Z, Wang X, Huang C, Wang M, Cui W, Hao L Mater Today Bio. 2025; 31:101599.

PMID: 40070870 PMC: 11894339. DOI: 10.1016/j.mtbio.2025.101599.


The Physiological Functions and Therapeutic Potential of Hypoxia-Inducible Factor-1α in Vascular Calcification.

Zhang Z, Wang D, Xu R, Li X, Wang Z, Zhang Y Biomolecules. 2025; 14(12.

PMID: 39766299 PMC: 11674127. DOI: 10.3390/biom14121592.


Calciprotein particles induce arterial stiffening ex vivo and impair vascular cell function.

Neutel C, Wesley C, van Loo C, Civati C, Mertens F, Zurek M Commun Biol. 2024; 7(1):1241.

PMID: 39358413 PMC: 11447031. DOI: 10.1038/s42003-024-06895-y.


Mineralo-organic particles inhibit influenza A virus infection by targeting viral hemagglutinin activity.

Chiang H, Peng H, Weng K, Hsiung K, Liang C, Kuo S Nanomedicine (Lond). 2024; 19(28):2375-2390.

PMID: 39320315 PMC: 11492690. DOI: 10.1080/17435889.2024.2403326.


Association of serum zinc with mineral stress in chronic kidney disease.

Sohail A, Obereigner J, Mitter G, Schmid T, Hofer A, Schuster G Clin Kidney J. 2024; 17(9):sfae258.

PMID: 39286240 PMC: 11403325. DOI: 10.1093/ckj/sfae258.